Abbott Laboratories disclosed late Wednesday that it has agreed to with Japanese partner Takeda Pharmaceuticals to split up their decades-old drug-making joint venture, TAP Pharmaceuticals.
Takeda, Japan's biggest drug producer, has long been interested in taking full control of the venture, which the two companies formed in 1977. But the two partners have reportedly had difficulty in the past settling on a buyout price.
Under the accord the two companies announced today, they will "evenly divide the value" of the joint venture.
More at the Trib
Showing posts with label TAP. Show all posts
Showing posts with label TAP. Show all posts
Wednesday, March 19, 2008
Tip top TAP
Takeda, Japan's largest drug maker, plans to buy out Abbott's stake in their 50-50 U.S. joint venture, TAP, for 500 billion yen ($5 billion), a source close to the deal said on Wednesday.
Reuters
Now what might Abbott want the cash for? What with all the pharma companies trading at near 52 week lows an' all.
Reuters
Now what might Abbott want the cash for? What with all the pharma companies trading at near 52 week lows an' all.
Monday, April 16, 2007
Subscribe to:
Posts (Atom)